Ontology highlight
ABSTRACT:
SUBMITTER: Tanaka K
PROVIDER: S-EPMC7118370 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
Tanaka Keisuke K Kuboki Mai M Koi Satoshi S Toyota Shigeo S
Internal medicine (Tokyo, Japan) 20191122 6
Nivolumab exerts therapeutic activity in patients with classic Hodgkin's lymphoma (CHL) but may cause several types of immune-related adverse events. Some rheumatoid arthritis (RA) patients develop CHL during methotrexate therapy (MTX-CHL); however, the efficacy and safety of nivolumab for these patients remain unclear. A 68-year-old woman was diagnosed with CHL after six years of MTX therapy for RA. The disease did not respond to any type of chemotherapy. Nivolumab was then initiated, and the p ...[more]